Iovance Biotherapeutics Inc
F:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
C
|
China Merchants Port Holdings Co Ltd
F:CPM
|
HK |
|
A
|
Advantest Corp
XMUN:VAN
|
JP |
|
A
|
Advantest Corp
F:VAN
|
JP |
|
C
|
China Merchants Port Holdings Co Ltd
XMUN:CPM
|
HK |
Intrinsic Value
Is 2LB undervalued or overvalued?
See the intrinsic value estimate for 
Iovance Biotherapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Iovance Biotherapeutics Does
Iovance Biotherapeutics develops cell therapies for cancer, with a focus on tumor-infiltrating lymphocyte, or TIL, treatments. These are personalized medicines made from a patient’s own immune cells, expanded in the lab, and given back as a treatment that can help the body attack tumors. The company’s main product work centers on making and commercializing these therapies for patients with certain solid tumors.
- Headquarters
- United States of America US
- Employees
- 975
- IPO date
- Jun 20, 2008
Revenue & Expenses Breakdown
Iovance Biotherapeutics Inc
Earnings Waterfall
Iovance Biotherapeutics Inc
The intrinsic value for Iovance Biotherapeutics Inc (2LB) under the Base Case is hidden EUR.
Compared with the current market price of 13.22 EUR, the stock appears hidden.